GNLX Earnings Date: Nov 4, 2026 (Estimated) — Genelux Corporation
NASDAQ · Healthcare · Biotechnology
Updated
When is GNLX's next earnings date?
Genelux Corporation (GNLX) is expected to report Q3 2026 earnings on Wednesday, November 4, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.20.
How did GNLX do in its last earnings report?
In its most recent report on Aug 13, 2026 (Q2 2026), Genelux Corporation posted EPS of -$0.21 versus the -$0.20 estimate, a miss of 5.0%. Revenue was $0. The stock's 1-day post-earnings move was -2.6%.
How much does GNLX stock move after earnings?
GNLX beat EPS estimates in 2 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 12.9% (up or down) in the day after earnings.
About Genelux Corporation
Genelux Corporation is a clinical-stage biopharmaceutical company focused on pioneering advanced oncolytic viral immunotherapies for patients confronting aggressive and/or hard-to-treat solid tumor malignancies. Its leading experimental drug, Olvi-Vec, is a proprietary, engineered vaccinia virus strain being developed to address ovarian cancer and non-small cell lung cancer. The company is also advancing V2ACT Immunotherapy for pancreatic cancer, alongside V-VET1 for the treatment of both hematologic and solid cancers. Founded in 2001, Genelux maintains its headquarters in Westlake Village, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 | Q2 2026 | -0.20 | -0.21 | -5.00% | $0 | ❌ Miss | -2.59% | -0.74% | -7.78% |
| 2026-05-07 | Q1 2026 | -0.19 | -0.20 | -5.26% | $0 | ❌ Miss | +9.89% | +7.42% | +3.53% |
| 2026-03-19 | Q4 2025 | -0.22 | -0.24 | -9.09% | $0 | ❌ Miss | -5.51% | +3.54% | +4.33% |
| 2025-11-05 | Q3 2025 | -0.22 | -0.21 | +4.55% | $0 | ✅ Beat | -32.40% | -24.36% | -40.82% |
| 2025-03-28 | Q4 2024 | -0.19 | -0.25 | -31.58% | $0 | ❌ Miss | -12.34% | -22.40% | -3.57% |
| 2024-11-14 | Q3 2024 | -0.18 | -0.19 | -5.56% | $0 | ❌ Miss | -19.73% | -16.33% | -19.73% |
| 2024-08-14 | Q2 2024 | -0.24 | -0.22 | +8.33% | $0 | ✅ Beat | +1.91% | -1.91% | +16.75% |
| 2024-04-01 | Q4 2023 | -0.19 | -0.25 | -31.58% | $0 | ❌ Miss | -18.51% | -23.33% | -50.70% |
Showing last 8 quarters.